BR112023018839A2 - Composto de glutarimida substituído por anel fundido com furano - Google Patents

Composto de glutarimida substituído por anel fundido com furano

Info

Publication number
BR112023018839A2
BR112023018839A2 BR112023018839A BR112023018839A BR112023018839A2 BR 112023018839 A2 BR112023018839 A2 BR 112023018839A2 BR 112023018839 A BR112023018839 A BR 112023018839A BR 112023018839 A BR112023018839 A BR 112023018839A BR 112023018839 A2 BR112023018839 A2 BR 112023018839A2
Authority
BR
Brazil
Prior art keywords
furan
ring fused
compound replaced
glutarimide
glutarimide compound
Prior art date
Application number
BR112023018839A
Other languages
English (en)
Inventor
Chen Shuhui
Lei Maoyi
Li Junmiao
Original Assignee
Medshine Discovery Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medshine Discovery Inc filed Critical Medshine Discovery Inc
Publication of BR112023018839A2 publication Critical patent/BR112023018839A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/496—Non-condensed piperazines containing further heterocyclic rings, e.g. rifampin, thiothixene or sparfloxacin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50—Pyridazines; Hydrogenated pyridazines
    • A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Furan Compounds (AREA)

Abstract

composto de glutarimida substituído por anel fundido com furano. é divulgada uma série de compostos de glutarimida substituídos por anel fundido com furano e uma aplicação dos mesmos na preparação de um medicamento para o tratamento de doenças relacionadas. em particular, é divulgado um composto representado pela fórmula (ii) ou um sal farmaceuticamente aceitável do mesmo.
BR112023018839A 2021-03-17 2022-03-16 Composto de glutarimida substituído por anel fundido com furano BR112023018839A2 (pt)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
CN202110286500 2021-03-17
CN202110712765 2021-06-25
CN202111314330 2021-11-08
CN202210187905 2022-02-28
PCT/CN2022/081261 WO2022194221A1 (zh) 2021-03-17 2022-03-16 呋喃稠环取代的戊二酰亚胺类化合物

Publications (1)

Publication Number Publication Date
BR112023018839A2 true BR112023018839A2 (pt) 2023-12-26

Family

ID=83322066

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112023018839A BR112023018839A2 (pt) 2021-03-17 2022-03-16 Composto de glutarimida substituído por anel fundido com furano

Country Status (9)

Country Link
EP (1) EP4310083A1 (pt)
JP (1) JP2024511342A (pt)
KR (1) KR20230154953A (pt)
CN (1) CN116940568A (pt)
AU (1) AU2022240688A1 (pt)
BR (1) BR112023018839A2 (pt)
CA (1) CA3212104A1 (pt)
TW (1) TWI807697B (pt)
WO (1) WO2022194221A1 (pt)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024037616A1 (zh) * 2022-08-19 2024-02-22 正大天晴药业集团股份有限公司 包含环己基的化合物
WO2024055994A1 (zh) * 2022-09-14 2024-03-21 南京明德新药研发有限公司 萘并呋喃取代的戊二酰亚胺类化合物的晶型、制备方法及其应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HRP20230414T1 (hr) * 2016-10-11 2023-07-07 Arvinas Operations, Inc. Spojevi i postupci za ciljanu razgradnju androgenog receptora
US11319330B2 (en) * 2018-09-07 2022-05-03 Medshine Discovery Inc. Tricyclic furan-substituted piperidinedione compound
JP7098825B2 (ja) * 2018-09-07 2022-07-11 メッドシャイン ディスカバリー インコーポレイテッド 三環式置換ピペリジンジオン類化合物
WO2021185291A1 (zh) * 2020-03-17 2021-09-23 南京明德新药研发有限公司 蛋白降解调节剂与其使用方法

Also Published As

Publication number Publication date
CN116940568A (zh) 2023-10-24
CA3212104A1 (en) 2022-09-22
AU2022240688A1 (en) 2023-11-02
TWI807697B (zh) 2023-07-01
TW202241404A (zh) 2022-11-01
KR20230154953A (ko) 2023-11-09
JP2024511342A (ja) 2024-03-13
WO2022194221A1 (zh) 2022-09-22
EP4310083A1 (en) 2024-01-24

Similar Documents

Publication Publication Date Title
BR112022012641A2 (pt) Compostos tricíclicos substituídos
PH12020551821A1 (en) Novel compounds
BR112023018839A2 (pt) Composto de glutarimida substituído por anel fundido com furano
BR112021024131A2 (pt) Derivado de anel inibidor de btk, método de preparação para o mesmo e aplicação farmacêutica do mesmo
BR112022010383A2 (pt) Compostos tricíclicos substituídos
EA201991693A1 (ru) Производное пиридина в качестве ингибитора ask1 и способ его получения и применения
EA201892216A1 (ru) Замещенные производные индолина в качестве ингибиторов репликации вирусов денге
EA202090486A3 (ru) Соединения для лечения спинальной мышечной атрофии
EA201892214A1 (ru) Замещенные производные индола в качестве ингибиторов репликации вирусов денге
EA202092168A1 (ru) Применение фавипиравира в лечении коронавирусной инфекции
WO2020113213A3 (en) Cyclic pantetheine derivatives and uses thereof
EA201992334A1 (ru) Замещенные производные индолина в качестве ингибиторов репликации вирусов денге
CO2021002976A2 (es) Amidas heterocíclicas de 5 a 7 miembros como inhibidores de jak
EA201200472A1 (ru) Сульфонамиды в качестве ингибиторов белков семейства bcl-2, предназначенные для лечения рака
AU2020288567A8 (en) Pyrrolopyrimidine compound and use thereof
BR112018016517A2 (pt) composições farmacêuticas incluindo uma droga antirretroviral e um intensificador farmacocinético
CY1124346T1 (el) ΠΑΡΑΓΩΓΑ ΧΡΩΜΑΝΙΟΥ, ΙΣΟΧΡΩΜΑΝΙΟΥ ΚΑΙ ΔΙΥΔΡΟΪΣΟΒΕΝΖΟΦΟΥΡΑΝΙΟΥ ΩΣ mGluR2-APNHTIKOI ΑΛΛΟΣΤΕΡΙΚΟΙ ΔΙΑΜΟΡΦΩΤΕΣ, ΣΥΝΘΕΣΕΙΣ, ΚΑΙ ΧΡΗΣΗ ΑΥΤΩΝ
BR112021011325A2 (pt) Derivados de rapamicina
CO2021014210A2 (es) Compuestos de pirrol
AR062401A1 (es) Uso de derivados del 2,5-dihidroxibenceno para tratar dermatitis
EA202192433A1 (ru) Соединения, полезные в терапии вич
EA202190398A1 (ru) Конденсированное кольцевое производное, применяемое в качестве ингибитора fgfr4
GB2590189A9 (en) Lycorine derivatives, pharmaceutical composite thereof and usage therefor
EA202193007A1 (ru) Соединения пирролидина
EA201691058A1 (ru) Производные пирролопирролона и их применение для лечения заболеваний